Daytime Urinary Incontinence clinical trials

Explore recruiting daytime urinary incontinence clinical trials.

Recruiting daytime urinary incontinence studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Daytime Urinary Incontinence trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effective strategy of withdrawal of pharmacological treatment of urinary incontinence in children (StayDry)

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Efficacy of solifenacin, mirabegron and combination therapy in children with overactive bladder and daytime urinary incontinence (BeDry)

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Daytime Urinary Incontinence trials by city

Daytime Urinary Incontinence in Toronto Daytime Urinary Incontinence in Vancouver Daytime Urinary Incontinence in Montreal Daytime Urinary Incontinence in Calgary Daytime Urinary Incontinence in Edmonton Daytime Urinary Incontinence in Ottawa Daytime Urinary Incontinence in Winnipeg Daytime Urinary Incontinence in Quebec City Daytime Urinary Incontinence in Hamilton Daytime Urinary Incontinence in Kitchener Daytime Urinary Incontinence in London Daytime Urinary Incontinence in Halifax Daytime Urinary Incontinence in New York Daytime Urinary Incontinence in Los Angeles Daytime Urinary Incontinence in Chicago Daytime Urinary Incontinence in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease